Nitya Raj

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors”.

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

British Journal of Cancer(2023)10.1038/s41416-023-02298-8

N/A

0.681DataRank · unranked

11 citations

Jennifer A. Chan, Stephanie J. Wang, Rahul Aggarwal, Susan Calabrese, April DeMore +13 more

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Annals of Surgical Oncology(2023)10.1245/s10434-023-14637-3

N/A

0DataRank · unranked

7 citations

Janet W. Y. Li, Megan Fiasconaro, Sabrina T. Lin, Marinela Capanu, David A. Kleiman +5 more

Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long-course chemoradiation versus short-course radiation therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.10

N/A

0DataRank · unranked

11 citations

Byung Kwan Park, David Nemirovsky, Janet Alvarez, Dana M. Omer, Reith Sarkar +15 more

Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy

Annals of Oncology(2024)10.1016/j.annonc.2024.07.729

N/A

0DataRank · unranked

27 citations

Byung Kwan Park, Emmanouil P. Pappou, Dmitry Nemirovsky, Reith Sarkar, Miles Yamner +34 more

Digitally Enabled Transitional Care Management in Oncology

JCO Oncology Practice(2024)10.1200/op.23.00565

N/A

0DataRank · unranked

10 citations

Jennifer R. Cracchiolo, Jessie C. Holland, Ann M. Mazzella Ebstein, Jessica Flynn, Elaine Duck +14 more

Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms

medRxiv(2025)10.1101/2025.06.24.25330227

N/A

0DataRank · unranked

2 citations

Salomon Tendler, Joanne F. Chou, Zeynep Tarcan, Courtney Porfido, Jonathan Willner +20 more

Alpelisib for Long-term Management of Tumor-Induced Hypoglycemia

AACE Endocrinology and Diabetes(2025)10.1016/j.aed.2025.03.010

N/A

0DataRank · unranked

0 citations

Nitya Raj, Diane Reidy‐Lagunes, Marcus D. Goncalves, James Flory, Tyler Ryan

Safety and efficacy of Yttrium-90 transarterial radioembolization of neuroendocrine liver metastasis – A retrospective single-institution study

European Journal of Radiology(2025)10.1016/j.ejrad.2025.112570

N/A

0DataRank · unranked

0 citations

Elena N. Petre, Harry Marquis, Adam Kesner, Steven Lundi, Lee Rodriguez +9 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0DataRank · unranked

652 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps515

N/A

0DataRank · unranked

9 citations

Katherine A. Guthrie, Syed A. Ahmad, M. Kay Washington, Brian Hemendra Ramnaraign, Nitya Raj +8 more